4basebio UK Societas (GB:4BB) has released an update.
4basebio PLC’s CEO, Dr. Heikki Lanckriet, has increased his stake in the company by acquiring 12,000 ordinary shares, bringing his total ownership to 7.27% of the issued share capital. This move signals confidence in the company’s direction, which focuses on synthetic DNA production and nanoparticle delivery solutions.
For further insights into GB:4BB stock, check out TipRanks’ Stock Analysis page.